Healthy Subjects
Conditions
Keywords
Supplemental ATP, Muscle Work Performed, Muscle Fatigue
Brief summary
Adenosine-triphosphate (ATP) serves as the sole energy source for muscle contraction. Therefore human performance of brief maximal exercise is limited, in part, by the availability of ATP to the contracting muscle. Because muscle ATP storage is small (enough to sustain maximal exercise for less than 1 second), factors that enhance either storage or resynthesis of ATP may have a positive impact on repeated muscle contractions. The current study will test the hypothesis that increasing ATP availability to muscle via oral supplementation will improve performance of repeated high intensity exercise as measured by a) work performed in each of the three 50 contraction fatigue tests, b) sum of total work performed, and c) percentage decrement in total work from the first to third third 50 contraction test.
Detailed description
To date we have studied 10 subjects who have followed through with all 3 of the original interventions (Placebo, 250 mg PeakATP/d and 400 mg PeakATP/d). Currently we have received approval and are expanding the study with 5 additional subjects who will receive the Placebo, 400 mg PeakATP/d and the 400 mg PealATP/d plus proprietary blend interventions.
Interventions
The nutritional intervention provides for oral ingestion of 250 mg PeakATP per day
Placebo capsules that are comparable in size and color to the active comparator for blinding purposes
The nutritional intervention provides for oral ingestion of 400 mg PeakATP per day
The nutritional intervention provides for oral ingestion of 400 mg PeakATP per day plus a proprietary blend of additional nutrients
Sponsors
Study design
Eligibility
Inclusion criteria
* No major medical conditions; * Able to perform fatigue testing procedures; * Not currently taking prescription medications; * Not currently taking dietary supplements (a daily multi-vitamin not exceeding RDA is permitted)
Exclusion criteria
* Major medical condition affecting metabolism or general function; * Not able to perform fatigue testing; * Taking prescription medications; * Taking a dietary supplement other than a multi-vitamin not exceeding RDA
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Work Performed | Measured after 15 days of intervention | The work and total work performed in 3 exercise fatigue tests given after 15 days of nutritional intervention. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Decrease in work performed in each successive test | Measured after 15 days of intervention | The decrease in total work performed in each of 3 successive fatigue tests will be measured and used as a measure of muscle fatigability after 15 days of nutritional intervention |
Countries
United States